Clinical Trials Logo

Clinical Trial Summary

The study is conducted to examine the suitability of partially respectively extensively hydrolyzed low protein infant formulae with and without pro- and prebiotics for healthy, term infants.

Primary hypothesis to be tested is: an infant formula based on a Protein hydrolysate with modified protein content is non inferior compared to a standard infant formula based on a Protein hyrolysate in respect to proper growth of healthy, term infants within the first four month of life.

4-year follow-up (without further Intervention) will focus on body composition and allergic predisposition.


Clinical Trial Description

View Section Brief Summary ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01143233
Study type Interventional
Source HiPP GmbH & Co. Vertrieb KG
Contact
Status Completed
Phase N/A
Start date April 2010
Completion date August 2017